about
Autophagy of mitochondria: a promising therapeutic target for neurodegenerative disease.Modelling the cost effectiveness of interferon beta and glatiramer acetate in the management of multiple sclerosis. Commentary: evaluating disease modifying treatments in multiple sclerosis.The future of multiple sclerosis therapies: redesigning multiple sclerosis clinical trials in a new therapeutic era.Disease progression among multiple sclerosis patients before and during a disease-modifying drug program: a longitudinal population-based evaluation.
P2860
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Competing interests in multiple sclerosis research.
@en
Competing interests in multiple sclerosis research.
@nl
type
label
Competing interests in multiple sclerosis research.
@en
Competing interests in multiple sclerosis research.
@nl
prefLabel
Competing interests in multiple sclerosis research.
@en
Competing interests in multiple sclerosis research.
@nl
P1433
P1476
Competing interests in multiple sclerosis research.
@en
P2093
John Noseworthy
Martin Daumer
P304
P356
10.1016/S0140-6736(03)12354-9
P407
P577
2003-01-01T00:00:00Z